| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.1 | 0.04 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.04 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.04 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.04 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.04 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.068 | 0.04 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.04 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.061 | 0.05 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.05 |